Chronic Obstructive Pulmonary Disease (COPD) is a progressive lung disease characterized by difficulty in breathing, coughing, and sputum production. It is a leading cause of morbidity and mortality worldwide, necessitating an in-depth understanding of its diagnosis and treatment strategies among healthcare professionals.
Diagnosis of COPD primarily involves identifying symptoms and risk factors, followed by spirometry to confirm airflow obstruction. The presence of a post-bronchodilator FEV1/FVC ratio of less than 0.70 confirms persistent airflow limitation and thus COPD. High-resolution computed tomography (HRCT) can be used in doubtful cases or for phenotyping.
The mainstay of COPD treatment is bronchodilator therapy, including long-acting beta-agonists (LABAs) and long-acting muscarinic antagonists (LAMAs). Inhaled corticosteroids (ICS) are reserved for frequent exacerbators with eosinophilic inflammation. Pulmonary rehabilitation, oxygen therapy, and lifestyle modifications are also integral parts of management.
Acute exacerbations, characterized by an acute worsening of respiratory symptoms, require prompt treatment with bronchodilators, corticosteroids, and antibiotics. Non-invasive ventilation is beneficial in cases of acute respiratory failure. Early hospitalization is recommended for severe exacerbations.
Emerging therapies for COPD include dual bronchodilation, roflumilast for chronic bronchitis phenotype, and endobronchial valves for severe emphysema. Research into novel therapies like stem cell therapy and gene therapy is ongoing.
In conclusion, COPD is a complex disease requiring a comprehensive approach to diagnosis and treatment. A clear understanding of the disease pathology, diagnostic modalities, and treatment strategies is essential for healthcare professionals to manage this condition effectively and improve patient outcomes.
1.
FDA Declines to Approve Achieve Life Sciences' Smoking-cessation Drug
2.
Uncovered biology underlies a novel drug used to treat triple-negative breast cancer.
3.
Chemotherapy damage to non-cancer cells may be the cause of breast cancer recurrence.
4.
Never in a million years did I think I'd have to limit my chemotherapy.
5.
Treating Depression: Crucial for Recovery From Fibromyalgia
1.
HCC in Melanoma: Role of HCC Codes and Moderate Whole Body Hyperthermia
2.
Clinical Analysis of Prostate Cancer
3.
Sorafenib: Understanding the science behind a powerful cancer drug
4.
Early-Onset GI Cancers: Screening, AI Innovations & Research Advances 2025
5.
Comprehensive Breakthroughs in Oncology for Better Care
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Understanding the Evolution in Lung Cancer- An Initiative from Manipal Hospitals: Further Discussion
2.
Experts' Opinion on the Goal of Treatment of Patients with Relapsed Adult B-cell ALL
3.
A Continuation to Deep Dive Into EGFR Mutation Positive Non-Small Cell Lung Cancer
4.
EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion & Conclusion
5.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation